{"result": {"id": "caef1cde-352e-4d1a-b3b2-4e16e55260ea", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>阿普昔腾坦<|>PERSON<|>阿普昔腾坦是一种降压药物，25mg剂量在第40周时持续降压有效，耐受性良好，但可能导致胎儿严重出生缺陷，禁用于妊娠妇女\")\n##\n(\"entity\"<|>二甲双胍<|>PERSON<|>二甲双胍是一种降糖药，具有降压效应\")\n##\n(\"entity\"<|>胰高血糖素样肽1受体激动剂<|>PERSON<|>胰高血糖素样肽1受体激动剂（GLP-1RA）是一种降糖药，具有降压效应\")\n##\n(\"entity\"<|>钠-葡萄糖协同转运蛋白2抑制剂<|>PERSON<|>钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）是一种降糖药，具有降压效应\")\n##\n(\"entity\"<|>高血压综合防治研究<|>EVENT<|>高血压综合防治研究（CHIEF）是一项研究，表明小剂量长效二氢吡啶类CCB+ARB用于高血压患者初始治疗有效\")\n##\n(\"relationship\"<|>阿普昔腾坦<|>二甲双胍<|>阿普昔腾坦和二甲双胍都是具有降压效果的药物<|>3)\n##\n(\"relationship\"<|>阿普昔腾坦<|>胰高血糖素样肽1受体激动剂<|>阿普昔腾坦和胰高血糖素样肽1受体激动剂都是具有降压效果的药物<|>3)\n##\n(\"relationship\"<|>阿普昔腾坦<|>钠-葡萄糖协同转运蛋白2抑制剂<|>阿普昔腾坦和钠-葡萄糖协同转运蛋白2抑制剂都是具有降压效果的药物<|>3)\n##\n(\"relationship\"<|>二甲双胍<|>胰高血糖素样肽1受体激动剂<|>二甲双胍和胰高血糖素样肽1受体激动剂都是具有降压效果的降糖药<|>4)\n##\n(\"relationship\"<|>二甲双胍<|>钠-葡萄糖协同转运蛋白2抑制剂<|>二甲双胍和钠-葡萄糖协同转运蛋白2抑制剂都是具有降压效果的降糖药<|>4)\n##\n(\"relationship\"<|>胰高血糖素样肽1受体激动剂<|>钠-葡萄糖协同转运蛋白2抑制剂<|>胰高血糖素样肽1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂都是具有降压效果的降糖药<|>4)\n##\n(\"relationship\"<|>高血压综合防治研究<|>阿普昔腾坦<|>高血压综合防治研究涉及降压药物的研究，包括阿普昔腾坦<|>2)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558626, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 598, "prompt_tokens": 2475, "total_tokens": 3073, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 683}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: mg和 25mg的降压效果均优于安慰剂 ,阿普 昔腾坦 25mg在第 40周时持续降压有效 。 阿普昔腾 坦耐受性良好 ,最常见的不良事件是轻中度水肿或水 潴留。\n　　　阿普昔腾坦可能会导致胎儿的严重出生缺陷 ,故 禁用于妊娠妇女。\n　　　(11)其他具有降压效应的药物 :降糖药二甲双胍、 胰高血糖素样肽 1(glucagon like peptide-1 ,GLP-1)\n\n\n受体激动剂 (GLP-1 receptor agonist, GLP-1RA) 及  钠-葡萄糖协同转运蛋白 2抑制剂(sodium-glucoseco- transporter2inhibitor,SGLT2i) 的相关研究及荟萃分  析显示具有一定幅度的减重、降压作用[128,298] 。对于  具有使用上述药物适应证的高血压患者 ,可以酌情与  降压药联合使用。\n　5.2.2.4  降压药的联合应用    联合应用降压药疗效 显著增强 ,是实现降压目标的有效治疗方法[232] 。为 了达到目标血压水平 ,大部分高血压患者都需要使用 2种或 2种以上降压药。\n　　　(1)联合用药的适应证 : 2级以上高血压(≥160/ 100mmHg) 、高于目标血压 20/10mmHg的心血管  风险高危/很高危的患者 ,初始治疗即可应用 2种降压  药 。1级高血压患者 ,也可考虑初始小剂量联合降压  药治疗 。如不能达到目标血压 ,可在原有小剂量药物  治疗基础上加量 ,也可加用第 3种甚至第 4种降压药。\n　　　(2)联合用药的方法 :两药联合时 , 降压作用机制  应具有互补性 ,具有相加的降压作用 ,和互相抵消或减  轻不良反应 。例如 ,在应用 ACEI或 ARB基础上加用  小剂量噻嗪类利尿剂 , 降压效果可以达到甚至超过原  有的 ACEI或 ARB剂量倍增后的降压幅度 。ACEI 或 ARB加用二氢吡啶类 CCB也有相似效果。\n　　　(3)两种药物的联合方案 :①ACEI或 ARB+噻嗪  类利尿剂 ,ACEI和 ARB可使血钾水平略有上升 , 能  拮抗噻嗪类利尿剂长期应用所致的低血钾等不良反  应 。ACEI或 ARB+噻嗪类利尿剂合用有协同作用 ,  有利于增强降压效果 。②二氢吡啶类 CCB+ACEI或  ARB,CCB具有直接扩张动脉血管的作用 , ACEI或  ARB既扩张小动脉、又扩张小静脉 ,故两药合用有协  同降压作用 。二氢吡啶类 CCB常见的不良反应为踝  部水肿 ,可被 ACEI或 ARB减轻或抵消 。高血压综合  防治研究(Chinese hypertension intervention efficacy study,CHIEF)[234] 表明 ,小剂量长效二氢吡啶类 CCB+  ARB用于高血压患者初始治�\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_b8f34e0d838ecb983e318ae6c497ca9de91a7c3d25858eb691b953d5fa9691b2_v2"}